Hitoshi Wada
Overview
Explore the profile of Hitoshi Wada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
463
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saito T, Shikama N, Takahashi T, Harada H, Nakamura N, Notsu A, et al.
J Palliat Med
. 2024 Dec;
28(1):42-49.
PMID: 39729365
Utility values of responders and nonresponders are essential inputs in cost-effectiveness studies of radiation therapy for painful bone metastases but, to our knowledge, they have not been reported separately. We...
2.
Utsumi N, Saito T, Shikama N, Takahashi T, Harada H, Nakamura N, et al.
Jpn J Clin Oncol
. 2024 Oct;
55(2):140-147.
PMID: 39479804
Objective: Single-center studies or randomized controlled trials have evaluated the impact of radiotherapy for bone metastases on quality of life (QOL). We investigated the real-world impact of radiotherapy for bone...
3.
Harada H, Shikama N, Notsu A, Shirato H, Yamada K, Uezono H, et al.
J Radiat Res
. 2024 Aug;
65(5):701-711.
PMID: 39162649
Purpose of this study is to evaluate patient characteristics, treatments and outcomes in bone metastasis radiotherapy practice. Patients for whom radiotherapy for bone metastasis was planned at 26 institutions in...
4.
Saito T, Shikama N, Takahashi T, Harada H, Ueno S, Notsu A, et al.
Br J Radiol
. 2023 Sep;
96(1151):20230351.
PMID: 37750858
Objective: To identify factors significantly associated with quality of life (QOL) and determine if these associations are strong enough to predict certain aspects of QOL without measuring them. Methods: We...
5.
Sekii S, Saito T, Kosugi T, Nakamura N, Wada H, Tonari A, et al.
Clin Transl Radiat Oncol
. 2023 Jul;
42:100657.
PMID: 37457019
Purpose: Although the Palliative Prognostic Index (PPI) has been used to predict survival in various cancers, to our knowledge, no study has examined its applicability in gastric cancer. This study...
6.
Shirato H, Harada H, Iwasaki Y, Notsu A, Yamada K, Uezono H, et al.
Adv Radiat Oncol
. 2023 Apr;
8(4):101205.
PMID: 37077179
Purpose: The aim of this study was to understand the income and employment status of patients at the start of and during follow-up after palliative radiation therapy for bone metastasis....
7.
Tokumaru S, Ishikawa H, Soejima T, Kimoto T, Takakusagi Y, Tamamura H, et al.
J Radiat Res
. 2023 Apr;
64(Supplement_1):i16-i24.
PMID: 37036770
This study aimed to evaluate the efficacy and safety of particle therapy (proton beam therapy and carbon-ion radiotherapy) for esophageal cancer by analyzing prospective nationwide registry data from particle therapy...
8.
Saito T, Shikama N, Takahashi T, Miwa M, Miyazawa K, Wada H, et al.
Adv Radiat Oncol
. 2022 Feb;
7(2):100856.
PMID: 35146217
Purpose: A quality indicator (QI) is a valuable tool to evaluate the quality of health care systems. In palliative radiation oncology, only a few related QIs have been developed to...
9.
Saito T, Kosugi T, Nakamura N, Wada H, Tonari A, Ogawa H, et al.
Gastric Cancer
. 2021 Sep;
25(2):411-421.
PMID: 34580795
Background: Palliative radiotherapy seems to be rarely performed for incurable gastric cancer. In this first multicenter study, we examined the effectiveness of palliative radiotherapy and investigated whether biologically effective dose...
10.
Azami Y, Wada H, Seto I, Azami A, Sato A, Suzuki N, et al.
Gan To Kagaku Ryoho
. 2021 May;
48(5):705-707.
PMID: 34006719
Intramedullary spinal cord metastasis(ISCM)is rare. However, with advances in diagnostic imaging, the incidence of ISCM is increasing. We herein present a case of breast cancer metastasis in the lower thoracic...